Sign in
4

Changes in Ownership

AEON Biopharma, Inc. Filed Acc 0001104659-23-083567

Options or other derivatives

  • Chief Medical Officer acquired 361,167 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Oh Chad · Chief Medical Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-07-21 Grant or award : show line 1 in the form Stock Option +145,588 145,588 D
2023-07-21 Grant or award : show line 2 in the form Stock Option +115,151 115,151 D
2023-07-21 Grant or award : show line 3 in the form Restricted Stock Units +100,428 100,428 D
Loading xslF345X05/tm2321918-10_4seq1.xml…